Yesterday, ERBA Diagnostics announced that it has launched its fifth wholly owned subsidiary, ERBA Diagnostics Mexico S.A. The company and its subsidiaries develop, manufacture, and distribute proprietary diagnostic reagents, test kits, and instrumentation for autoimmune and infectious diseases.

Mexico’s IVD market is estimated by to be worth approximately $400 million. Immunochemistry, hematology/coagulation, and chemistry/urine analysis products comprise the majority of the market’s profits. ERBA Diagnostics focuses on these market segments, which is expected to create additional business opportunities in the near future. The company notes that the Mexican market for diagnostics is expected to grow approximately 15% per year.

ERBA Mexico is currently in the process of hiring sales specialists and customer support engineers for its Mexico City location. The sales and service training center will provide better support to ERBA Diagnostics’ distributors and customers throughout Latin America, with the ultimate goal of increasing sales and improving brand image.

For more information, please visit www.erbadiagnostics.com

Let us hear your thoughts below: